Merck KGaA’s Praziquantel Donation Program, in partnership with the World Health Organization (WHO), aims to fight schistosomiasis in Africa. Schistosomiasis is a parasitic worm disease that is the second most prevalent and devastating parasitic disease in tropical countries after malaria. Infection occurs when human skin comes into contact with fresh water contaminated by snails carrying the schistosome parasites, which migrate through the body and spread the infectious disease. It represents the 2nd most severe burden for African children after malaria, and is considered as one of the most neglected tropical diseases. The consequences of an infection are particularly serious for children, as schistosomiasis stunts growth and cognitive development and also lead to anemia. WHO reports more than 200 million infected people in Americas, Africa, the Middle East, Southeast and the Western Pacific.